Intrasubject correlation between static scan and distribution volume images for [11C]flumazenil PET

Annals of Nuclear Medicine

Volumn 14, Issue 3, 2000, Pages 193-198

  Mishina, Masahiro ^a,c   Senda, Michio ^c   Kimura, Yuichi ^c   Toyama, Hinako ^b,c   Ishiwata, Kiishi ^c   Ohyama, Masashi ^a,b   Nariai, Tadashi ^b,d   Ishii, Kenji ^b   Oda, Kei Ichi ^b   Sasaki, Toru ^b   Kitamura, Shin ^a   Katayama, Yasuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Benzodiazepine receptor; Pixel correlation; Positron emission tomography; Static scan; 11C flumazenil

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; FLUMAZENIL;

ADULT; ARTICLE; BRAIN SCINTISCANNING; CLINICAL ARTICLE; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG LABELING; DRUG RECEPTOR BINDING; DRUG TISSUE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; ISOTOPE LABELING; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RADIATION MEASUREMENT; RADIOISOTOPE DECAY; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; TIME;

ADULT; BIOTRANSFORMATION; BRAIN; CARBON RADIOISOTOPES; FEMALE; FLUMAZENIL; HUMANS; KINETICS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; ORGAN SPECIFICITY; RECEPTORS, GABA-A; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033914648     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02987859     Document Type: Article

References (14)

1. Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widen L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 2: 863-866, 1988.
2. Holthoff VA, Koeppe RA, Frey KA, Penney JB, Markel DS, Kuhl DE, et al. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease. Ann Neurol 34: 76-81, 1993.
3. Gilman S, Koeppe RA, Junck L, Kluin KJ, Lohman M, St Laurent RT. Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography. Ann Neurol 38: 176-185, 1995.
4. Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE. Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Arch Neurol 52: 314-317, 1995.
5. Gilman S, Koeppe RA, Adams K, Johnson-Greene D, Junck L, Kluin KJ, et al. Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics. Ann Neurol 40: 163-171, 1996.
6. 123I-IMP. KAKU IGAKU (Jpn J Nucl Med) 33: 49-56, 1996.
7. Ohyama M, Senda M, Ishiwata K, Kitamura S, Mishina M, Ishii K, et al. Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF. Ann Nucl Med 13: 309-315, 1999.
8. Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 30: 663-672, 1991.
9. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11: 735-744, 1991.
10. 11C]flumazenil. J Cereb Blood Flow Metab 13: 656-667, 1993.
11. Millet P, Delforge J, Mauguiere F, Pappata S, Cinotti L, Frouin V, et al. Parameter and index images of benzodiazepine receptor concentration in the brain. J Nucl Med 36: 1462-1471, 1995.
12. Iida H, Miura S, Kanno I, Murakami M, Takahashi K, Uemura K. Design and evaluation of HEADTOME-IV, a whole-body positron emission tomograph. IEEE Trans Nucl Sci NS-36: 1006-1010, 1989.
13. 11C]flumazenil in human plasma: Assessment as the standardized value for quantitative PET study. Ann Nucl Med 12: 55-59, 1998.
14. Toyama H, Yamada T, Uemura K, Kimura Y, Ishii K, Ohyama M, et al. Quantitative mapping of benzodiazepine receptor concentration in a static PET study. NeuroImage 5: A34, 1997.